Stoke Therapeutics 2
Pharma & Biotech company headquartered in Bedford, MA. Cross-border supply chain, facility locations, and freight intelligence below.
Stoke Therapeutics STK-001 antisense oligonucleotide upregulates SCN1A for Dravet syndrome.
- Industry
- Pharma & Biotech
- Headquarters
- Bedford, MA
- US facilities
- Bedford, MA
Start a free trial to see Stoke Therapeutics 2’s full freight profile — facility network, cross-border lanes, and shipper intelligence.